Rusan Pharma launches ‘No Reason is Good Enough’ to promote tobacco de-addiction
2baconil is available in nicotine patches and gums
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Rusan Pharma
NSRT to start Phase II trial of Eflornithine granules to treat COVID-19 by early Jan 2021
The company aims to complete the study by March 2021
Rusan Pharma launches R&D centre at Kandla SEZ
Rusan Pharma signs $20 million per annum deal with Brazil Health Ministry for smoking cessation programme
Rusan Pharma launches first ‘Made in India’ NRT patch 2baconil
Designed for humid climates; to co-partner with Brazilian govt in early May